Terminal complement inhibition and control of hemolysis in patients with paroxysmal nocturnal hemoglobinuria who switched from high-dose eculizumab to ravulizumab: a phase IV, single-arm clinical trial.
No Thumbnail Available
All Authors
Griffin, M.
Gandhi, S.
Kelly, RJ.
Munir, T.
Trikha, R.
Hicks, E.
Jain, D.
Ogawa, M.
Yu, J.
Muus, P.
LTHT Author
Griffin, Morag
Kelly, Richard
Munir, Talha
Muus, Petra
Kelly, Richard
Munir, Talha
Muus, Petra
LTHT Department
Haematology
Non Medic
Publication Date
2025
Item Type
Journal Article
Language
Subject
Subject Headings
Abstract
Journal
Haematologica